IndraLab

Statements

JOSD2 inhibits CRC. 1 / 1

| 1

reach

"This provides a strong indication that the observed anti-tumor effects of HY041004 in vivo are indeed mainly through JOSD2 inhibition.Taken together, these data collectively demonstrated depletion of JOSD2 or pharmacological inhibiting JOSD2 significantly suppressed the growth of CRC in vitro and in vivo, especially KRAS-mutant CRC."

40240366

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

JOSD2 inhibits CRC. 1 / 1

INDRA sources:

Databases

Reading